Frontiers in Immunology | Alloimmunity and Transplantation

Original Research

Published on 12 Sep 2025

Age-enhanced MAGIC algorithm predicts mortality in pediatric aGVHD: a multicenter study

in Alloimmunity and Transplantation

Na Song
Hao Xiong
Ri Xu
Wen-Geng Cheng
Shan He
Shaoyang Deng
Benshan Zhang
Dao Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1660861

1,814 views

Systematic Review

Published on 12 Sep 2025

Association of donor-specific antibodies with adverse outcomes in solid organ transplantation: A systematic review and meta-analysis of 69 studies

in Alloimmunity and Transplantation

Zhong-yu Kang
Xue-ya Han
Chun Liu
Wei Liu
Dai-hong Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1633853

3,093 views

Mini Review

Published on 09 Sep 2025

Immunocompatibility in transplantation: adapting to a changing therapeutic landscape

in Alloimmunity and Transplantation

Raquel Güell-Alonso
Raquel Cabrera-Pérez
Joaquim Vives

Frontiers in Immunology

doi 10.3389/fimmu.2025.1648534

2,250 views
1 citation

Original Research

Published on 08 Sep 2025

The impact of pharmacists’ interventions within the closed loop immunosuppressant management process on kidney transplant recipients: a retrospective cohort study

in Alloimmunity and Transplantation

Hongxia Chen
Chuan Li
Shengsong Ou
Xiaoyu Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1553786

3,133 views

Original Research

Published on 05 Sep 2025

Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience

in Alloimmunity and Transplantation

Fiorella Calabrese
Federica Pezzuto
Luca Vedovelli
Cecilia De Chellis
Francesca Lunardi
Monica Loy
Eleonora Faccioli
Marta Vadori
Davide Biondini
Serena Marinello

Frontiers in Immunology

doi 10.3389/fimmu.2025.1619771

1,967 views

Case Report

Published on 04 Sep 2025

Case Report: Adjuvant splenic irradiation therapy effectively eliminates donor-specific antibodies and reverses refractory early active antibody-mediated rejection after presensitized kidney transplantation

in Alloimmunity and Transplantation

Zhiliang Guo
Rula Sa
Guangyuan Zhao
Fuheng Che
Hui Guo
Lan Zhu
Gang Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1670507

1,928 views

Original Research

Published on 04 Sep 2025

Inhibition of HMGB1/NF-κB signaling restores Th17/Treg balance via dendritic cell modulation in liver transplant rejection

in Alloimmunity and Transplantation

Linyu Li
Jie Wang
Liyun Huang
Yi Chen
Lihong Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1649366

2,433 views
1 citation

Original Research

Published on 03 Sep 2025

Structural valve deterioration is primarily caused by cyclic fatigue but not immune rejection

in Alloimmunity and Transplantation

Alexander E. Kostyunin
Tatiana V. Glushkova
Evgeny A. Ovcharenko
Pavel S. Onischenko
Kirill Yu. Klyshnikov
Tatiana N. Akentieva
Leo A. Bogdanov
Vladislav A. Koshelev
Alexander N. Stasev
Anton A. Khromov

Frontiers in Immunology

doi 10.3389/fimmu.2025.1652294

1,821 views

Original Research

Published on 02 Sep 2025

Lipid biomarkers of GVHD in allogeneic stem hematopoietic cell transplantation patients

in Alloimmunity and Transplantation

Zhi Lin
Jie Shen
Yicheng Fu
Jiao Liu
Lu Yan
Xin Li
Minghua Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1624168

1,750 views

Original Research

Published on 29 Aug 2025

High-level ePVS was accompanied by an increase in kidney transplant failure risk: analysis based on the MIMIC-IV database

in Alloimmunity and Transplantation

Zhirong Zhou
Lin Zhang
Delin Zhang
Yan Yang
Shuiping Ou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1574525

1,791 views

Original Research

Published on 28 Aug 2025

Use of HLA desensitization in the management of renal transplant recipients in Europe

in Alloimmunity and Transplantation

Lionel P. E. Rostaing
Georg A. Böhmig
Muhammed Mahdi Taqi
Ben Gibbons

Frontiers in Immunology

doi 10.3389/fimmu.2025.1451135

2,411 views

Original Research

Published on 28 Aug 2025

Serum proteomics analysis of lung transplant patients receiving different induction therapies

in Alloimmunity and Transplantation

Shahrooz Nasrollahi-Shirazi
Markus Unterwurzacher
Hatice Oya Berezhinskiy
Sophia Alemanno
Konrad Hoetzenecker
Clemens Aigner
Peter Jaksch
Thomas Mohr
Klaus Kratochwill
Alberto Benazzo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1616781

1,917 views

Original Research

Published on 26 Aug 2025

Prediction and effect on relapse of natural killer cell alloreactivity based on KIR-HLA interactions in pediatric haploidentical transplantation with anti-thymoglobulin

in Alloimmunity and Transplantation

Xiang-Feng Tang
Yan-Hui Luo
Ying-Jian Si
Mao-Quan Qin
Wei Lu
Wei Chen
Guo-Sheng Xing
Wei Cao
Hai-Fei Zhou
Xiang-Jun Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1643244

1,683 views

Review

Published on 19 Aug 2025

Immune-evasive beta cells in type 1 diabetes: innovations in genetic engineering, biomaterials, and computational modeling

in Alloimmunity and Transplantation

Ismail Can Karaoglu
Doğukan Duymaz
Mudassir M. Rashid
Seda Kizilel

Frontiers in Immunology

doi 10.3389/fimmu.2025.1618086

5,551 views
1 citation

Original Research

Published on 18 Aug 2025

Ruxolitinib and decitabine plus a busulfan–cyclophosphamide conditioning regimen for relapse prophylaxis in patients with high-risk acute myeloid leukemia or myelodysplastic syndromes

in Alloimmunity and Transplantation

Yujun Wei
Songhua Luan
Lu Wang
Lili Wang
Fei Li
Xiangshu Jin
Ruoling Yang
Kun Qian
Bo Peng
Jingwen Tang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1586512

3,540 views

Brief Research Report

Published on 15 Aug 2025

Post-transplant cyclophosphamide in haploidentical stem cell transplantation: evaluating the impact of transplant conditioning intensity

in Alloimmunity and Transplantation

Umberto Pizzano
Simona Piemontese
Gabriele Facchin
Raffaella Greco
Marta Lisa Battista
Jacopo Peccatori
Renato Fanin
Fabio Ciceri
Francesca Patriarca
Maria Teresa Lupo-Stanghellini

Frontiers in Immunology

doi 10.3389/fimmu.2025.1610391

1,676 views

Brief Research Report

Published on 14 Aug 2025

Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome

in Alloimmunity and Transplantation

Edoardo Campodonico
Piera Angelillo
Matteo Doglio
Alessia Ugolini
Maria Teresa Lupo Stanghellini
Maddalena Noviello
Elena Tassi
Federica Pedica
Gregorio Maria Bergonzi
Lorenzo Lazzari

Frontiers in Immunology

doi 10.3389/fimmu.2025.1635062

2,662 views
2 citations

Original Research

Published on 13 Aug 2025

Successful treatment of transplant-associated thrombotic microangiopathy with iptacopan: a non-adult case study

in Alloimmunity and Transplantation

Shijie Bao
Kaikai Huang
Xiao Huang
Huamin Zhu
Zhiqiang Sun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1583506

2,891 views

Original Research

Published on 12 Aug 2025

Risk assessment of antibody-mediated damage based on the detection of HLA and non-HLA antibodies toward extracellular antigens before kidney transplantation

in Alloimmunity and Transplantation

Eulàlia Solà-Porta
Dolores Redondo-Pachón
Jorge Eguía-Núñez
Anna Buxeda
José Luís Caro
Javier Gimeno
Luís Campuzano
Carla Burballa
Betty Chamoun
Sara Sanz-Ureña

Frontiers in Immunology

doi 10.3389/fimmu.2025.1614408

1,975 views

Original Research

Published on 08 Aug 2025

Impact of viral load kinetics and recurrent cytomegalovirus infection in kidney transplantation

in Alloimmunity and Transplantation

Sabina Dobrer
Karen R. Sherwood
Kimberly Davis
James H. Lan
John Gill
Nancy Matic
Paul A. Keown

Frontiers in Immunology

doi 10.3389/fimmu.2025.1600289

2,809 views
1 citation

Review

Published on 08 Aug 2025

Optimizing anti-thymocyte globulin dosing in allogeneic hematopoietic stem cell transplantation: individualized approaches and clinical implications

in Alloimmunity and Transplantation

Haitao Wang
Hongqi Yang
Jishan Du
Liping Dou
Daihong Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1634157

2,697 views

Original Research

Published on 06 Aug 2025

Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes

in Alloimmunity and Transplantation

Alberto Mella
Roberta Clari
Valeria Deiana
Roberta Giraudi
Gloria Giovinazzo
Ester Gallo
Caterina Dolla
Antonio Lavacca
Ana Maria Manzione
Fabrizio Fop

Frontiers in Immunology

doi 10.3389/fimmu.2025.1629521

2,280 views
2 citations

Review

Published on 04 Aug 2025

Navigating challenges in human pluripotent stem cell-derived islet therapy for type 1 diabetes

in Alloimmunity and Transplantation

Mohammed Usama
Ying Deng
Yiran Chen
Théa Milland
Mohan Malleshaiah
Yasaman Aghazadeh

Frontiers in Immunology

doi 10.3389/fimmu.2025.1625439

3,903 views

Case Report

Published on 01 Aug 2025

Effective treatment with daratumumab in post-HSCT refractory immune-mediated cytopenias: a case report and literature review

in Alloimmunity and Transplantation

Xiao-yu Jing
Dong-jun Li
Sheng-nan Su
Qing-kai Dai
Shu-wen Sun
Liang Huang
Yuan Ai
Ju Gao
Yi-Ping Zhu
Jia-qi Ni

Frontiers in Immunology

doi 10.3389/fimmu.2025.1625365

4,350 views

1,814 articles

articles

Age-enhanced MAGIC algorithm predicts mortality in pediatric aGVHD: a multicenter study

Association of donor-specific antibodies with adverse outcomes in solid organ transplantation: A systematic review and meta-analysis of 69 studies

Immunocompatibility in transplantation: adapting to a changing therapeutic landscape

The impact of pharmacists’ interventions within the closed loop immunosuppressant management process on kidney transplant recipients: a retrospective cohort study

Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience

Case Report: Adjuvant splenic irradiation therapy effectively eliminates donor-specific antibodies and reverses refractory early active antibody-mediated rejection after presensitized kidney transplantation

Inhibition of HMGB1/NF-κB signaling restores Th17/Treg balance via dendritic cell modulation in liver transplant rejection

Structural valve deterioration is primarily caused by cyclic fatigue but not immune rejection

Lipid biomarkers of GVHD in allogeneic stem hematopoietic cell transplantation patients

High-level ePVS was accompanied by an increase in kidney transplant failure risk: analysis based on the MIMIC-IV database

Use of HLA desensitization in the management of renal transplant recipients in Europe

Serum proteomics analysis of lung transplant patients receiving different induction therapies

Prediction and effect on relapse of natural killer cell alloreactivity based on KIR-HLA interactions in pediatric haploidentical transplantation with anti-thymoglobulin

Immune-evasive beta cells in type 1 diabetes: innovations in genetic engineering, biomaterials, and computational modeling

Ruxolitinib and decitabine plus a busulfan–cyclophosphamide conditioning regimen for relapse prophylaxis in patients with high-risk acute myeloid leukemia or myelodysplastic syndromes

Post-transplant cyclophosphamide in haploidentical stem cell transplantation: evaluating the impact of transplant conditioning intensity

Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome

Successful treatment of transplant-associated thrombotic microangiopathy with iptacopan: a non-adult case study

Risk assessment of antibody-mediated damage based on the detection of HLA and non-HLA antibodies toward extracellular antigens before kidney transplantation

Impact of viral load kinetics and recurrent cytomegalovirus infection in kidney transplantation

Optimizing anti-thymocyte globulin dosing in allogeneic hematopoietic stem cell transplantation: individualized approaches and clinical implications

Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes

Navigating challenges in human pluripotent stem cell-derived islet therapy for type 1 diabetes

Effective treatment with daratumumab in post-HSCT refractory immune-mediated cytopenias: a case report and literature review